A roadmap for serum biomarkers for hepatitis B virus: current status and future outlook

Nature Reviews Gastroenterology & Hepatology, Published online: 20 July 2022; doi:10.1038/s41575-022-00649-zCurrently, there is no cure for hepatitis B virus (HBV) infection, which can lead to chronic liver disease and liver cancer, and only a few biomarkers are available. This Roadmap provides an overview of HBV serum biomarkers and their challenges.

Source: Nature Reviews Gastroenterology and Hepatology - July 20, 2022 Category: Gastroenterology Authors: Anna Kramvis Kyong-Mi Chang Maura Dandri Patrizia Farci Dieter Glebe Jianming Hu Harry L. A. Janssen Daryl T. Y. Lau Capucine Penicaud Teresa Pollicino Barbara Testoni Florian Van B ömmel Ourania Andrisani Maria Beumont-Mauviel Timothy M. Block Henry L. Source Type: research